Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Roger

Showing results (161-170 of 180) with videos related to

Pageof 18
Sort By:
Nature Communications|November 16, 2019
A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertensionNadine D Arnold, Josephine A Pickworth, Laura E West, et al.
American Journal of Respiratory and Critical Care Medicine|May 1, 2020
Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical OutcomeChristopher J Rhodes, Pablo Otero-Núñez, John Wharton, et al.
Cell Metabolism|December 11, 2020
Neutrophils Fuel Effective Immune Responses through Gluconeogenesis and GlycogenesisPranvera Sadiku, Joseph A Willson, Eilise M Ryan, et al.
Lancet (London, England)|July 18, 2021
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort studyThomas M Drake, Aya M Riad, Cameron J Fairfield, et al.
Genome Research|October 13, 2009
The NIH Human Microbiome Project, Jane Peterson, Susan Garges, et al.
Nature Communications|December 8, 2021
Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole bloodSokratis Kariotis, Emmanuel Jammeh, Emilia M Swietlik, et al.
The European Respiratory Journal|July 8, 2020
EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multicentre studyRobert A Lewis, Iain Armstrong, Carmel Bergbaum, et al.
The Lancet. Respiratory Medicine|July 1, 2022
Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysisMarius M Hoeper, Krit Dwivedi, Christine Pausch, et al.
Advances in Nutrition (Bethesda, Md.)|August 7, 2019
Perspective: Dietary Biomarkers of Intake and Exposure-Exploration with Omics ApproachesPadma Maruvada, Johanna W Lampe, David S Wishart, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 29, 2026
Longitudinal <sup>1</sup>H and <sup>129</sup>Xe Lung MRI in Patients With Post-COVID Residual Lung AbnormalitiesLaura C Saunders, Guilhem J Collier, Laurie J Smith, et al.
Pageof 18

Showing results (161-170 of 180) with videos related to

Sort By:
Pageof 18
Nature Communications|November 16, 2019
A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertensionNadine D Arnold, Josephine A Pickworth, Laura E West, et al.
American Journal of Respiratory and Critical Care Medicine|May 1, 2020
Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical OutcomeChristopher J Rhodes, Pablo Otero-Núñez, John Wharton, et al.
Cell Metabolism|December 11, 2020
Neutrophils Fuel Effective Immune Responses through Gluconeogenesis and GlycogenesisPranvera Sadiku, Joseph A Willson, Eilise M Ryan, et al.
Lancet (London, England)|July 18, 2021
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort studyThomas M Drake, Aya M Riad, Cameron J Fairfield, et al.
Genome Research|October 13, 2009
The NIH Human Microbiome Project, Jane Peterson, Susan Garges, et al.
Nature Communications|December 8, 2021
Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole bloodSokratis Kariotis, Emmanuel Jammeh, Emilia M Swietlik, et al.
The European Respiratory Journal|July 8, 2020
EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multicentre studyRobert A Lewis, Iain Armstrong, Carmel Bergbaum, et al.
The Lancet. Respiratory Medicine|July 1, 2022
Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysisMarius M Hoeper, Krit Dwivedi, Christine Pausch, et al.
Advances in Nutrition (Bethesda, Md.)|August 7, 2019
Perspective: Dietary Biomarkers of Intake and Exposure-Exploration with Omics ApproachesPadma Maruvada, Johanna W Lampe, David S Wishart, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 29, 2026
Longitudinal <sup>1</sup>H and <sup>129</sup>Xe Lung MRI in Patients With Post-COVID Residual Lung AbnormalitiesLaura C Saunders, Guilhem J Collier, Laurie J Smith, et al.
Pageof 18